{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T06:09:06Z","timestamp":1788588546789,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.eimce.2022.12.010","type":"journal-article","created":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T07:30:54Z","timestamp":1673076654000},"page":"629-634","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Treatment and prevention of monkeypox"],"prefix":"10.1016","volume":"41","author":[{"given":"Fernando","family":"de la Calle-Prieto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Est\u00e9banez Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germ\u00e1n","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"D\u00edaz-Men\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harkaitz","family":"Azkune Galparsoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Salavert Llet\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Mata Forte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Mora-Rillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Arsuaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"de Miguel Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Ram\u00f3n","family":"Arribas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Javier","family":"Membrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimce.2022.12.010_bib0005","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.3390\/v12111257","article-title":"Monkeypox Virus in Nigeria: infection biology, epidemiology, and evolution","volume":"12","author":"Alakunle","year":"2020","journal-title":"Viruses."},{"key":"10.1016\/j.eimce.2022.12.010_bib0010","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3201\/eid2608.191387","article-title":"Imported Monkeypox, Singapore","volume":"26","author":"Yong","year":"2020","journal-title":"Emerg Infect Dis."},{"key":"10.1016\/j.eimce.2022.12.010_bib0015","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.pop.2015.08.006","article-title":"Viral skin diseases","volume":"42","author":"Ramdass","year":"2015","journal-title":"Prim Care."},{"key":"10.1016\/j.eimce.2022.12.010_bib0020","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.idc.2019.03.001","article-title":"Human Monkeypox: epidemiologic and clinical characteristics, diagnosis, and prevention","volume":"33","author":"Petersen","year":"2019","journal-title":"Infect Dis Clin North Am."},{"key":"10.1016\/j.eimce.2022.12.010_bib0025","doi-asserted-by":"crossref","first-page":"638","DOI":"10.2471\/BLT.19.242347","article-title":"Modelling human-to-human transmission of monkeypox","volume":"98","author":"Grant","year":"2020","journal-title":"Bull World Health Organ."},{"key":"10.1016\/j.eimce.2022.12.010_bib0030","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1093\/cid\/ciaa143","article-title":"Clinical course and outcome of Human Monkeypox in Nigeria","volume":"71","author":"Ogoina","year":"2020","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimce.2022.12.010_bib0035","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.22.2200411","article-title":"Monkeypox infection presenting as genital rash, Australia, May 2022","volume":"27","author":"Hammerschlag","year":"2022","journal-title":"Euro Surveill."},{"key":"10.1016\/j.eimce.2022.12.010_bib0040","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S1473-3099(22)00228-6","article-title":"Clinical features and management of human monkeypox: a retrospective observational study in the UK","volume":"22","author":"Adler","year":"2022","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.eimce.2022.12.010_bib0045","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2207323","article-title":"Monkeypox virus infection in humans across 16 countries - April-June 2022","author":"Thornhill","year":"2022","journal-title":"N Engl J Med."},{"key":"10.1016\/j.eimce.2022.12.010_bib0050","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/14787210.2020.1819791","article-title":"An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications","volume":"19","author":"Russo","year":"2021","journal-title":"Expert Rev Anti Infect Ther."},{"key":"10.1016\/j.eimce.2022.12.010_bib0055","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.vaccine.2019.10.049","article-title":"Co-administration of tecovirimat and ACAM2000\u2122 in non-human primates: effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge","volume":"38","author":"Russo","year":"2020","journal-title":"Vaccine."},{"key":"10.1016\/j.eimce.2022.12.010_bib0060","unstructured":"European Medicines Agency. Tecovirimat SIGA [accessed 4 Jul 2022]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/tecovirimat-siga."},{"key":"10.1016\/j.eimce.2022.12.010_bib0065","unstructured":"Food and Drugs Administration. Highlights of Prescribing Information. TPOXX\u00ae [accessed 4 Jul 2022]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/214518s000lbl.pdf."},{"key":"10.1016\/j.eimce.2022.12.010_bib0070","unstructured":"ClinicalTrials. Tecovirimat Intravenous Treatment for Orthopox Virus Exposure (TPOXX IV) [accessed 4 Jul 2022]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05380752."},{"key":"10.1016\/j.eimce.2022.12.010_bib0075","unstructured":"Centers for Disease Control and Prevention. Guidance for Tecovirimat Use Under Expanded Access Investigational New Drug Protocol during 2022 U.S. Monkeypox Cases [accessed 16 Jul 2022]. Available from: https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/Tecovirimat.html."},{"key":"10.1016\/j.eimce.2022.12.010_bib0080","unstructured":"European Medicines Agency. Tecovirimat SIGA, tecovirimat monohydrate. Annex I. Summary of Product Characteristics [accessed 4 Jul 2022]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/tecovirimat-siga-epar-product-information_en.pdf."},{"key":"10.1016\/j.eimce.2022.12.010_bib0085","first-page":"e00927","article-title":"Pharmacokinetics and efficacy of a Potential Smallpox Therapeutic Brincidofovir, in a Lethal Monkeypox Virus Animal Model","volume":"6","author":"Hutson","year":"2021","journal-title":"mSphere."},{"key":"10.1016\/j.eimce.2022.12.010_bib0090","unstructured":"Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Brincidofovir [accessed 4 Jul 2022]. Available from: https:\/\/www.aeped.es\/comite-medicamentos\/pediamecum\/brincidofovir."},{"key":"10.1016\/j.eimce.2022.12.010_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105182","article-title":"Benefit-risk assessment for brincidofovir for the treatment of smallpox: U.S. Food and Drug Administration\u2019s Evaluation","volume":"195","author":"Chan-Tack","year":"2021","journal-title":"Antiviral Res."},{"key":"10.1016\/j.eimce.2022.12.010_bib0100","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3390\/v12020138","article-title":"Smallpox in the post-eradication era","volume":"12","author":"Meyer","year":"2020","journal-title":"Viruses."},{"key":"10.1016\/j.eimce.2022.12.010_bib0105","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios. Ficha t\u00e9cnica cidofovir trillomed 75 mg\/ml concentrado para soluci\u00f3n para perfusi\u00f3n EFG [accessed 4 Jul 2022]. Available from: https:\/\/cima.aemps.es\/cima\/dochtml\/ft\/81303\/FT_81303.html."},{"key":"10.1016\/j.eimce.2022.12.010_bib0110","doi-asserted-by":"crossref","first-page":"509","DOI":"10.15585\/mmwr.mm7114a1","article-title":"Monkeypox in a Traveler Returning from Nigeria - Dallas, Texas, July 2021","volume":"71","author":"Rao","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.1016\/j.eimce.2022.12.010_bib0115","unstructured":"Ministerio de Sanidad. Alerta de viruela del mono en Espa\u00f1a y a nivel mundial [accessed 22 Jul 2022]. Available from: https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/ccayes\/alertasActual\/alertaMonkeypox\/home.htm."},{"key":"10.1016\/j.eimce.2022.12.010_bib0120","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.3201\/eid2704.203569","article-title":"Reemergence of Human Monkeypox and Declining Population Immunity in the Context of Urbanization, Nigeria, 2017-2020","volume":"27","author":"Nguyen","year":"2021","journal-title":"Emerg Infect Dis."},{"key":"10.1016\/j.eimce.2022.12.010_bib0125","doi-asserted-by":"crossref","first-page":"734","DOI":"10.15585\/mmwr.mm7122e1","article-title":"Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: recommendations of the Advisory Committee on Immunization Practices - United States, 2022","volume":"71","author":"Rao","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.1016\/j.eimce.2022.12.010_bib0130","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nm917","article-title":"Duration of antiviral immunity after smallpox vaccination","volume":"9","author":"Hammarlund","year":"2003","journal-title":"Nat Med."},{"key":"10.1016\/j.eimce.2022.12.010_bib0135","unstructured":"U.S. Food and Drug Administration. JYNNEOS [accessed 4 Jul 2022]. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/jynneos."},{"key":"10.1016\/j.eimce.2022.12.010_bib0140","unstructured":"ClinicalTrials.gov. Cohort Study of Healthcare Workers Receiving Imvanex\u00ae [accessed 16 Jul 2022]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03745131."}],"container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X2200301X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X2200301X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:02:19Z","timestamp":1762866139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2529993X2200301X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S2529993X2200301X"],"URL":"https:\/\/doi.org\/10.1016\/j.eimce.2022.12.010","relation":{},"ISSN":["2529-993X"],"issn-type":[{"value":"2529-993X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment and prevention of monkeypox","name":"articletitle","label":"Article Title"},{"value":"Enfermedades infecciosas y microbiologia clinica (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimce.2022.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.eimc.2022.08.001","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}